{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:42:43Z","timestamp":1792701763686,"version":"4.5.0"},"reference-count":20,"publisher":"MyJove Corporation","issue":"56","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/3334","type":"journal-article","created":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T16:48:35Z","timestamp":1320684515000},"source":"Crossref","is-referenced-by-count":9,"title":["Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence"],"prefix":"10.3791","author":[{"given":"Dana","family":"Faratian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gustavson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"InHwa","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2011,10,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2559.2011.03771.x","type":"journal-article","article-title":"Cytogenetic heterogeneity of pancreatic ductal adenocarcinomas: identification of intratumoral pathways of clonal evolution","volume":"58","author":"Gutierrez","year":"2011","unstructured":"Gutierrez, M.L., Sayagues, J.M., Del Mar, A.M., et al. Cytogenetic heterogeneity of pancreatic ductal adenocarcinomas: identification of intratumoral pathways of clonal evolution. Histopathology. 58 (3), 486-497 (2011).","journal-title":"Histopathology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nature09515","type":"journal-article","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","unstructured":"Yachida, S., Jones, S., Bozic, I., et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 467 (7319), 1114-1117 (2010).","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2559.2011.03771.x","type":"journal-article","article-title":"Cytogenetic heterogeneity of pancreatic ductal adenocarcinomas: identification of intratumoral pathways of clonal evolution","volume":"58","author":"Gutierrez","year":"2011","unstructured":"Gutierrez, M.L., Sayagues, J.M., Del Mar, A.M., et al. Cytogenetic heterogeneity of pancreatic ductal adenocarcinomas: identification of intratumoral pathways of clonal evolution. Histopathology. 58 (3), 486-497 (2011).","journal-title":"Histopathology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nature09515","type":"journal-article","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","unstructured":"Yachida, S., Jones, S., Bozic, I., et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 467 (7319), 1114-1117 (2010).","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1021\/nn100213v","type":"journal-article","article-title":"Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots","volume":"4","author":"Liu","year":"2010","unstructured":"Liu, J., Lau, S.K., Varma, V.A., et al. Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano. 4 (5), 2755-2765 (2010).","journal-title":"ACS Nano"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm791","type":"journal-article","article-title":"Automated subcellular localization and quantification of protein expression in tissue microarrays","volume":"8","author":"Camp","year":"2002","unstructured":"Camp, R.L., Chung, G.G., & Rimm, D.L. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat. Med. 8 (11), 1323-1327 (2002).","journal-title":"Nat. Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/163688a0","type":"journal-article","article-title":"Measurement of biodiversity","volume":"163","author":"Simpson","year":"1949","unstructured":"Simpson, E.H. Measurement of biodiversity. Nature. 163, 688 (1949).","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/PAI.0b013e318195ecaa","type":"journal-article","article-title":"Development of an unsupervised pixel-based clustering algorithm for compartmentalization of immunohistochemical expression using Automated Quantitative Analysis","volume":"17","author":"Gustavson","year":"2009","unstructured":"Gustavson, M.D., Bourke-Martin, B., Reilly, D.M., et al. Development of an unsupervised pixel-based clustering algorithm for compartmentalization of immunohistochemical expression using Automated Quantitative Analysis. Appl. Immunohistochem. Mol. Morphol. 17 (4), 329-337 (2009).","journal-title":"Appl. Immunohistochem. Mol. Morphol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(02)09738-6","type":"journal-article","article-title":"Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial","volume":"360","year":"2002","unstructured":"Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. Lancet. 360 (9332), 505-515 (2002).","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","type":"journal-article","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","unstructured":"McGuire, W.P., Hoskins, W.J., Brady, M.F., et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N. Engl. J. Med. 334 (1), 1-6 (1996).","journal-title":"N. Engl. J. Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2000.18.1.106","type":"journal-article","article-title":"Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study","volume":"18","author":"Muggia","year":"2000","unstructured":"Muggia, F.M., Braly, P.S., Brady, M.F., et al. Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study. J. Clin. Oncol. 18 (1), 106-115 (2000).","journal-title":"J. Clin. Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/92.9.699","type":"journal-article","article-title":"Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results","volume":"92","author":"Piccart","year":"2000","unstructured":"Piccart, M.J., Bertelsen, K., James, K., et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J. Natl. Cancer. Inst. 92 (9), 699-708 (2000).","journal-title":"J. Natl. Cancer. Inst"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","type":"journal-article","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","unstructured":"Cannistra, S.A. Cancer of the ovary. N. Engl. J. Med. 351 (24), 2519-2529 (2004).","journal-title":"N. Engl. J. Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1158\/1078-0432.CCR-05-0422","type":"journal-article","article-title":"Stability of phosphoprotein as a biological marker of tumor signaling","volume":"11","author":"Baker","year":"2005","unstructured":"Baker, A.F., Dragovich, T., Ihle, N.T., et al. Stability of phosphoprotein as a biological marker of tumor signaling. Clin. Cancer. Res. 11 (12), 4338-4340 (2005).","journal-title":"Clin. Cancer. Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/mcp.M700596-MCP200","type":"journal-article","article-title":"A portrait of tissue phosphoprotein stability in the clinical tissue procurement process","volume":"7","author":"Espina","year":"2008","unstructured":"Espina, V., Edmiston, K.H., Heiby, M., et al. A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol. Cell. Proteomics. 7 (10), 1998-2018 (2008).","journal-title":"Mol. Cell. Proteomics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2353\/ajpath.2009.080545","type":"journal-article","article-title":"Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe","volume":"174","author":"Klymkowsky","year":"2009","unstructured":"Klymkowsky, M.W. & Savagner, P. Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am. J. Pathol. 174 (5), 1588-1593 (2009).","journal-title":"Am. J. Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/stem.154","type":"journal-article","article-title":"Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells","volume":"27","author":"Kurrey","year":"2009","unstructured":"Kurrey, N.K., Jalgaonkar, S.P., Joglekar, A.V., et al. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem. Cells. 27 (9), 2059-2068 (2009).","journal-title":"Stem. Cells"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1073\/pnas.0905718106","type":"journal-article","article-title":"Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features","volume":"106","author":"Creighton","year":"2009","unstructured":"Creighton, C.J., Li, X., Landis, M. et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl. Acad. Sci. U. S. A. 106 (33), 13820-13825 (2009).","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/annonc\/mdp427","type":"journal-article","article-title":"Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases","volume":"21","author":"Aitken","year":"2010","unstructured":"Aitken, S.J., Thomas, J.S., Langdon, S.P., Harrison, D.J., & Faratian, D. Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Ann. Oncol. 21 (6), 1254-1261 (2010).","journal-title":"Ann. Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/path.2712","type":"journal-article","article-title":"Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis","volume":"221","author":"Sayagues","year":"2010","unstructured":"Sayagues, J.M., Abad, M.M., Melchor, H.B., et al. Intratumoural cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis. J. Pathol. 221 (3), 308-319 (2010).","journal-title":"J. Pathol"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jove.com\/video\/3334\/heterogeneity-mapping-protein-expression-tumors-using-quantitative","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:19:19Z","timestamp":1792700359000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/3334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,25]]},"references-count":20,"journal-issue":{"issue":"56","published-online":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.3791\/3334","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,25]]}}}